TipRanks
Supernus Pharmaceuticals (CH:S49)
:S49
Switzerland Market
S49
Supernus Pharmaceuticals
RESEARCH TOOLSreports

Supernus Pharmaceuticals (S49) Ratios

1 Followers

Supernus Pharmaceuticals Ratios

CH:S49's free cash flow for Q3 2026 was $0.88. For the 2026 fiscal year, CH:S49's free cash flow was decreased by $ and operating cash flow was $0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.49 1.90 2.35 1.70 1.07
Quick Ratio
 2.19 1.66 2.16 1.43 0.93
Cash Ratio
 0.62 0.38 0.24 0.26 0.14
Solvency Ratio
 0.17 0.14 0.46 0.24 0.18
Operating Cash Flow Ratio
 0.31 0.14 0.59 0.38 0.17
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.29
Net Current Asset Value
$ 376.00M$ 253.25M$ 353.73M$ 136.96M$ -82.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.03 0.26
Debt-to-Equity Ratio
 0.03 0.04 0.03 0.05 0.50
Debt-to-Capital Ratio
 0.03 0.04 0.03 0.04 0.33
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.32 1.37 1.32 1.39 1.92
Debt Service Coverage Ratio
 20.86 0.00 0.00 36.68 0.37
Interest Coverage Ratio
 -10.02 0.00 0.00 -2.18 6.52
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.21
Interest Debt Per Share
 0.67 0.73 0.62 0.81 8.42
Net Debt to EBITDA
 -2.17 -2.06 -0.20 -0.37 2.29
Profitability Margins
Gross Profit Margin
87.62%89.63%88.23%86.21%86.93%
EBIT Margin
-4.18%-6.82%14.79%0.85%10.16%
EBITDA Margin
7.44%5.92%26.94%14.82%22.98%
Operating Profit Margin
-3.51%-5.13%12.34%-0.87%6.91%
Pretax Profit Margin
-4.95%-6.82%14.79%0.46%9.10%
Net Profit Margin
-5.07%-5.36%11.16%0.22%9.10%
Continuous Operations Profit Margin
-5.07%-5.36%11.16%0.22%9.10%
Net Income Per EBT
102.46%78.63%75.47%47.53%99.95%
EBT Per EBIT
140.79%133.00%119.84%-52.55%131.69%
Return on Assets (ROA)
-3.14%-2.65%5.40%0.10%3.57%
Return on Equity (ROE)
-4.14%-3.63%7.13%0.14%6.85%
Return on Capital Employed (ROCE)
-2.73%-3.31%7.59%-0.53%4.55%
Return on Invested Capital (ROIC)
-2.71%-2.58%5.69%-0.25%3.24%
Return on Tangible Assets
-5.27%-5.08%10.13%0.23%6.88%
Earnings Yield
-1.80%-1.37%3.71%0.08%3.17%
Efficiency Ratios
Receivables Turnover
 4.03 3.83 4.66 4.21 4.03
Payables Turnover
 12.57 27.85 16.98 42.66 8.27
Inventory Turnover
 1.23 0.91 1.43 1.08 0.95
Fixed Asset Turnover
 26.15 68.27 57.32 44.90 43.98
Asset Turnover
 0.62 0.49 0.48 0.48 0.39
Working Capital Turnover Ratio
 2.16 2.06 2.22 4.88 4.01
Cash Conversion Cycle
 358.48 485.53 311.24 415.30 429.49
Days of Sales Outstanding
 90.59 95.34 78.36 86.61 90.53
Days of Inventory Outstanding
 296.92 403.30 254.37 337.24 383.08
Days of Payables Outstanding
 29.03 13.10 21.49 8.56 44.12
Operating Cycle
 387.51 498.64 332.73 423.85 473.61
Cash Flow Ratios
Operating Cash Flow Per Share
 1.52 0.84 3.12 2.04 2.18
Free Cash Flow Per Share
 1.49 0.81 3.11 2.03 2.17
CapEx Per Share
 0.02 0.02 0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.99 0.97 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 71.98 35.37 237.17 201.61 283.56
Capital Expenditure Coverage Ratio
 71.98 35.37 237.17 201.61 283.56
Operating Cash Flow Coverage Ratio
 2.44 1.16 5.02 2.68 0.26
Operating Cash Flow to Sales Ratio
 0.10 0.07 0.26 0.18 0.18
Free Cash Flow Yield
3.56%1.64%8.59%7.00%6.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -55.06 -73.09 26.99 1.20K 31.53
Price-to-Sales (P/S) Ratio
 2.82 3.90 3.01 2.60 2.87
Price-to-Book (P/B) Ratio
 2.30 2.64 1.92 1.71 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
 28.07 61.00 11.64 14.28 16.44
Price-to-Operating Cash Flow Ratio
 27.67 59.28 11.59 14.21 16.39
Price-to-Earnings Growth (PEG) Ratio
 0.70 0.48 <0.01 -12.25 2.65
Enterprise Value Multiple
 35.77 63.91 10.98 17.16 14.78
Enterprise Value
 2.30B 2.72B 1.96B 1.54B 2.27B
EV to EBITDA
 35.78 63.91 10.98 17.16 14.78
EV to Sales
 2.66 3.78 2.96 2.54 3.40
EV to Free Cash Flow
 26.47 59.10 11.43 13.98 19.46
EV to Operating Cash Flow
 26.10 57.43 11.38 13.91 19.40
Tangible Book Value Per Share
 8.54 6.51 7.20 3.75 1.24
Shareholders’ Equity Per Share
 18.25 18.81 18.80 16.90 16.51
Tax and Other Ratios
Effective Tax Rate
 -0.02 0.21 0.25 0.52 <0.01
Revenue Per Share
 14.86 12.74 12.01 11.14 12.43
Net Income Per Share
 -0.75 -0.68 1.34 0.02 1.13
Tax Burden
 1.02 0.79 0.75 0.48 1.00
Interest Burden
 1.18 1.00 1.00 0.53 0.90
Research & Development to Revenue
 0.14 0.15 0.16 0.15 0.11
SG&A to Revenue
 0.59 0.68 0.51 0.39 0.16
Stock-Based Compensation to Revenue
 0.07 0.05 0.04 0.04 0.03
Income Quality
 -1.13 -1.23 2.33 84.41 1.92
Currency in USD